Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC).

Joseph R. Osborne, Naveed Akhtar, Shankar Vallabhajosula, Anastasia Nikolopoulou, Kevin Maresca, Shawn Hillier, John L. Joyal, Robert Crummet, Thomas Armor, Scott T. Tagawa, David M. Nanus, Stanley J. Goldsmith, John W. BabichJournal of Clinical Oncology 2012 · DOI

Abstract

173 Background: Sensitive and specific imaging remains a clinically-relevant problem for men with PC. PSMA is a well established target for imaging of PC with therapeutic implications. We have recently developed novel 99m Tc-labeled small molecule inhibitors of the enzymatic domain of PSMA based on glutamate-urea-glutamate and glutamate-urea-lysine pharmacophores, and contain a bis-imidazole chelator to complex Tc-99m. Preclinical studies with PSMA positive LNCaP cells and xenografts demonstrate that 99m Tc-MIP-1404 and 99m Tc-MIP-1405 bind to PSMA with high affinity and localize in tumors rapidly. This study reports the first human data in men with metastatic PC and in healthy male subjects. Methods: Under an exploratory IND, using a cross-over design, the pharmacokinetics, biodistribution, and tumor uptake of 99m Tc-MIP-1404 and 99m Tc-MIP-1405 were compared in 6 healthy men and 6 men with radiographic evidence of metastatic PC. Whole body images were obtained at 10 min, 1, 2, 4 and 24 hr. Single photon emission computed tomography (SPECT) was performed between 3–4 hours post injection. Results: Both agents cleared the blood rapidly with MIP-1404 demonstrating significantly lower urinary activity (7%) compared to MIP-1405 (26%). Both agents showed persistent uptake in the salivary, lacrimal and parotid glands. Uptake in liver and kidney was acceptable for imaging at 1-2 hr post injection (PI). In men with PCa, both agents rapidly localized in bone and lymph node lesions as early as 1 hr PI. SPECT demonstrated excellent lesion contrast. Good correlation was seen with bone and CT scans, In majority of patients, more lesions including sub-cm lymph nodes were seen with 99m Tc-MIP-1404 and 99m Tc-MIP-1405. The high contrast images exhibited signal:noise ratios from 3:1 to 28:1 at 4 and 24 hr. Conclusions: 99m Tc-MIP-1404 and 99m Tc-MIP-1405 identified a greater number of lesions than bone scans and rapidly detected soft tissue PC lesions including sub-cm lymph nodes. Since 99m Tc-MIP-1404 has minimal activity in the bladder, further work is planned to correlate imaging findings with histopathology in patients with high risk clinically-localized PC.
BibTeX
@article{osborne2012tc,
  author = {Joseph R. Osborne and Naveed Akhtar and Shankar Vallabhajosula and Anastasia Nikolopoulou and Kevin Maresca and Shawn Hillier and John L. Joyal and Robert Crummet and Thomas Armor and Scott T. Tagawa and David M. Nanus and Stanley J. Goldsmith and John W. Babich},
  title = {{Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC).}},
  journal = {Journal of Clinical Oncology},
  year = {2012},
  doi = {10.1200/jco.2012.30.5\_suppl.173},
}

Loading related content...

Figure